These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16224736)

  • 21. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D; Gross-Tsur V
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
    Vaughan BS; Wetzel MW; Kratochvil CJ
    Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
    Harpin VA
    Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS; Aparasu RR
    Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; Newcorn JH; Kratochvil CJ; Gao H; Thomason CK; Rogers AK; Feldman PD; Levine LR
    J Pediatr; 2006 Jul; 149(1):112-9. PubMed ID: 16860138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
    Nair J; Ehimare U; Beitman BD; Nair SS; Lavin A
    Mo Med; 2006; 103(6):617-21. PubMed ID: 17256270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.
    Gerhard T; Winterstein AG; Olfson M; Huang C; Saidi A; Crystal S
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):457-64. PubMed ID: 20232490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
    Adler LA; Sutton VK; Moore RJ; Dietrich AP; Reimherr FW; Sangal RB; Saylor KE; Secnik K; Kelsey DK; Allen AJ
    J Clin Psychopharmacol; 2006 Dec; 26(6):648-52. PubMed ID: 17110824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
    Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
    J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
    Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
    Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Waxmonsky JG
    Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention deficit and hyperactivity disorder: review of genetic association studies.
    Galili-Weisstub E; Segman RH
    Isr J Psychiatry Relat Sci; 2003; 40(1):57-66. PubMed ID: 12817670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH; Kratochvil CJ; Allen AJ; Casat CD; Ruff DD; Moore RJ; Michelson D;
    Am J Psychiatry; 2008 Jun; 165(6):721-30. PubMed ID: 18281409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.